Goldman Sachs’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,285
Closed -$4.64K 6212
2023
Q1
$4.64K Sell
1,285
-282
-18% -$4.35K ﹤0.01% 5799
2022
Q4
$50.5K Sell
1,567
-136
-8% -$5.38K ﹤0.01% 5597
2022
Q3
$71K Sell
1,703
-399
-19% -$18.2K ﹤0.01% 5758
2022
Q2
$89K Sell
2,102
-596
-22% -$27.6K ﹤0.01% 5898
2022
Q1
$183K Buy
2,698
+205
+8% +$17.1K ﹤0.01% 5920
2021
Q4
$302K Buy
2,493
+568
+30% +$95.9K ﹤0.01% 5665
2021
Q3
$271K Buy
1,925
+586
+44% +$116K ﹤0.01% 5563
2021
Q2
$368K Buy
1,339
+636
+90% +$160K ﹤0.01% 5396
2021
Q1
$150K Buy
703
+142
+25% +$39.2K ﹤0.01% 5741
2020
Q4
$136K Buy
561
+51
+10% +$6.31K ﹤0.01% 5229
2020
Q3
$54K Buy
+510
New +$46.5K ﹤0.01% 5183
2019
Q3
Sell
-13,482
Closed -$2.42M 5445
2019
Q2
$2.42M Sell
13,482
-9
-0.1% -$1.46K ﹤0.01% 3404
2019
Q1
$2.16M Sell
13,491
-786
-6% -$156K ﹤0.01% 3597
2018
Q4
$3.71M Sell
14,277
-1,421
-9% -$286K ﹤0.01% 3126
2018
Q3
$3.82M Sell
15,698
-1,140
-7% -$298K ﹤0.01% 3177
2018
Q2
$3.97M Buy
+16,838
New +$4.91M ﹤0.01% 3119

Other funds holding EVLO